Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

nice_new_london_office_internal_3_web

Bayer’s Nubeqa secures NICE recommendation for hormone-relapsed prostate cancer at risk of metastasis

October 23, 2020 Medical Communications, Sales and Marketing Bayer, NCIE, Nubeqa, pharma

NICE has given its recommendation to Bayer’s androgen receptor inhibitor Nubeqa (darolutamide) in combination with androgen deprivation therapy (ADT) for …
News
generic-social-banners_v3_veeva-generic

Three Ways to Speed Your GxP Validation without Risk

October 23, 2020 Medical Communications, Research and Development

Computer system validation can often take months to complete. It typically involves infrastructure qualification (IQ), operational qualification (OQ), and performance …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

October 23, 2020 Medical Communications

The top ten news stories this week focus on coronavirus research, with the UK is set to be the first …
News
nice_new_london_office_internal_3_web

NICE approves Sanofi’s Sarclisa combo for relapsed/refractory multiple myeloma

October 16, 2020 Medical Communications, Sales and Marketing NICE, Sanofi, Sarclisa, multiple myeloma

Sanofi’s Sarclisa (isatuximab) has secured a recommendation from NICE for routine use on the NHS in England and Wales as …
News
shutterstock

Gilead’s remdesivir and three other repurposed drugs have no impact on COVID-19 mortality, WHO study finds

October 16, 2020 Medical Communications, Research and Development COVID-19, pharma, remdesivir

Gilead’s antiviral therapy remdesivir has emerged as one of the most promising drugs to treat COVID-19 infections, but recent studies …
News
the_stethoscope_peru

Five-year-old girl that was part of Lysogene’s gene therapy clinical trial dies

October 16, 2020 Medical Communications

A five-year-old girl had died while taking part in Lysogene’s clinical trial investigating its gene therapy. The child was suffering …
News
covid_cell_1

‘Long COVID’ could be taking four different forms

October 16, 2020 Medical Communications coronavirus, covid symptoms, long covid, symptoms

People experiencing chronic illnesses after COVID-19 infections could be suffering from one of four separate conditions, according to new research. …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

October 16, 2020 Medical Communications COVID, herd immunity, top ten, top ten articles

The top ten news stories this week focus on herd immunity, as the Director of the World Health Organization has …
News
piccadilly_circus_station_during_london_covid-19_lockdown

80 researchers argue COVID-19 herd immunity strategy is a “dangerous fallacy” in open letter

October 15, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19

A group of 80 researchers have lent their signatures to an open letter published in the The Lancet under the …
News

NICE recommends siponimod for treating secondary progressive MS

October 15, 2020 Medical Communications

The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending siponimod for treating secondary progressive multiple …
News

Dr Kevin Eggan named as Group Vice President, Head of Research and Early Development at BioMarin

October 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kevin Eggan, appointments

BioMarin Pharmaceutical has welcomed Dr Kevin Eggan as its new Group Vice President, Head of Research and Early Development. He …
Appointment
download_2

Dr Sarah Noonberg appointed Chief Medical Officer of Maze Therapeutics

October 9, 2020 Medical Communications

Maze Therapeutics has appointed Dr Sarah Noonberg as its Chief Financial Officer. Noonberg is a physician-scientist with expertise in global …
Appointment
shutterstock_273326141

Takeda and Arrowhead Pharma join forces in $1m rare liver disease drug development pact

October 9, 2020 Medical Communications, Research and Development Arrowhead, Takeda, pharma

A new partnership has been struck between Takeda and Arrowhead Pharmaceuticals, with both companies coming together to co-develop and license …
News
shutterstock

Amgen and Cytokinetics’ drug falls short in heart failure despite hitting primary goal

October 9, 2020 Medical Communications Amgen, cytokines, heart failure, pharma

New Phase 3 data has come to light on Amgen and Cytokinetics’ cardiac myosin activator therapy omecamtiv mecarbil fell short …
News
800px-us_supreme_court

US Supreme Court refuses Trump administration’s request to restrict delivery of abortion medication

October 9, 2020 Medical Communications abortion, abortion pill

The US Supreme Court has struck down a request from the Trump administration to restrict delivery of abortion medicine during …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026